Hostile takeover: Manipulation of HIF-1 signaling in pathogen-associated cancers (Review)
- Authors:
- Caixia Zhu
- Qing Zhu
- Chong Wang
- Liming Zhang
- Fang Wei
- Qiliang Cai
-
Affiliations: Key Laboratory of Medical Molecular Virology (Ministries of Education and Health), School of Basic Medical Sciences, Fudan University, Shanghai 200032, P.R. China, ShengYushou Center of Cell Biology and Immunology, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, P.R. China - Published online on: July 27, 2016 https://doi.org/10.3892/ijo.2016.3633
- Pages: 1269-1276
This article is mentioned in:
Abstract
 |
|
de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D and Plummer M: Global burden of cancers attributable to infections in 2008: A review and synthetic analysis. Lancet Oncol. 13:607–615. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Ackerman D and Simon MC: Hypoxia, lipids, and cancer: Surviving the harsh tumor microenvironment. Trends Cell Biol. 24:472–478. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Carmeliet P and Jain RK: Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov. 10:417–427. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Minet E, Michel G, Remacle J and Michiels C: Role of HIF-1 as a transcription factor involved in embryonic development, cancer progression and apoptosis (Review). Int J Mol Med. 5:253–259. 2000.PubMed/NCBI | |
|
Kurihara T, Westenskow PD and Friedlander M: Hypoxia-inducible factor (HIF)/vascular endothelial growth factor (VEGF) signaling in the retina. Adv Exp Med Biol. 801:275–281. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Calderwood MA, Venkatesan K, Xing L, Chase MR, Vazquez A, Holthaus AM, Ewence AE, Li N, Hirozane-Kishikawa T, Hill DE, et al: Epstein-Barr virus and virus human protein interaction maps. Proc Natl Acad Sci USA. 104:7606–7611. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Wakisaka N, Kondo S, Yoshizaki T, Murono S, Furukawa M and Pagano JS: Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha. Mol Cell Biol. 24:5223–5234. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Yang L, Liu L, Xu Z, Liao W, Feng D, Dong X, Xu S, Xiao L, Lu J, Luo X, et al: EBV-LMP1 targeted DNAzyme enhances radiosensitivity by inhibiting tumor angiogenesis via the JNKs/HIF-1 pathway in nasopharyngeal carcinoma. Oncotarget. 6:5804–5817. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Kondo S, Seo SY, Yoshizaki T, Wakisaka N, Furukawa M, Joab I, Jang KL and Pagano JS: EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1alpha through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells. Cancer Res. 66:9870–9877. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
O’Neil JD, Owen TJ, Wood VH, Date KL, Valentine R, Chukwuma MB, Arrand JR, Dawson CW and Young LS: Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro. J Gen Virol. 89:2833–2842. 2008. View Article : Google Scholar | |
|
Darekar S, Georgiou K, Yurchenko M, Yenamandra SP, Chachami G, Simos G, Klein G and Kashuba E: Epstein-Barr virus immortalization of human B-cells leads to stabilization of hypoxia-induced factor 1 alpha, congruent with the Warburg effect. PLoS One. 7:e420722012. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang JH, Wang N, Li A, Liao WT, Pan ZG, Mai SJ, Li DJ, Zeng MS, Wen JM and Zeng YX: Hypoxia can contribute to the induction of the Epstein-Barr virus (EBV) lytic cycle. J Clin Virol. 37:98–103. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Tang X, Zhang Q, Nishitani J, Brown J, Shi S and Le AD: Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells. Clin Cancer Res. 13:2568–2576. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Bodily JM, Mehta KP and Laimins LA: Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases. Cancer Res. 71:1187–1195. 2011. View Article : Google Scholar | |
|
An J, Mo D, Liu H, Veena MS, Srivatsan ES, Massoumi R and Rettig MB: Inactivation of the CYLD deubiquitinase by HPV E6 mediates hypoxia-induced NF-kappaB activation. Cancer Cell. 14:394–407. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Roman S, Jose-Abrego A, Fierro NA, Escobedo-Melendez G, Ojeda-Granados C, Martinez-Lopez E and Panduro A: Hepatitis B virus infection in Latin America: A genomic medicine approach. World J Gastroenterol. 20:7181–7196. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ali A, Abdel-Hafiz H, Suhail M, Al-Mars A, Zakaria MK, Fatima K, Ahmad S, Azhar E, Chaudhary A and Qadri I: Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma. World J Gastroenterol. 20:10238–10248. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yoo YG, Na TY, Seo HW, Seong JK, Park CK, Shin YK and Lee MO: Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells. Oncogene. 27:3405–3413. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Holotnakova T, Tylkova L, Takacova M, Kopacek J, Petrik J, Pastorekova S and Pastorek J: Role of the HBx oncoprotein in carbonic anhydrase 9 induction. J Med Virol. 82:32–40. 2010. View Article : Google Scholar | |
|
Matsuoka M and Jeang KT: Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 7:270–280. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Grassmann R, Aboud M and Jeang KT: Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene. 24:5976–5985. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Jeong SJ, Dasgupta A, Jung KJ, Um JH, Burke A, Park HU and Brady JN: PI3K/AKT inhibition induces caspase-dependent apoptosis in HTLV-1-transformed cells. Virology. 370:264–272. 2008. View Article : Google Scholar | |
|
Peloponese JM Jr and Jeang KT: Role for Akt/protein kinase B and activator protein-1 in cellular proliferation induced by the human T-cell leukemia virus type 1 tax oncoprotein. J Biol Chem. 281:8927–8938. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Tomita M, Semenza GL, Michiels C, Matsuda T, Uchihara JN, Okudaira T, Tanaka Y, Taira N, Ohshiro K and Mori N: Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells. Biochem J. 406:317–323. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Appel N, Schaller T, Penin F and Bartenschlager R: From structure to function: New insights into hepatitis C virus RNA replication. J Biol Chem. 281:9833–9836. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Tan A, Yeh SH, Liu CJ, Cheung C and Chen PJ: Viral hepatocarcinogenesis: From infection to cancer. Liver Int. 28:175–188. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Bergonzini V, Salata C, Calistri A, Parolin C and Palù G: View and review on viral oncology research. Infect Agent Cancer. 5:112010. View Article : Google Scholar : PubMed/NCBI | |
|
Martin D and Gutkind JS: Human tumor-associated viruses and new insights into the molecular mechanisms of cancer. Oncogene. 27(Suppl 2): S31–S42. 2008. View Article : Google Scholar | |
|
Nasimuzzaman M, Waris G, Mikolon D, Stupack DG and Siddiqui A: Hepatitis C virus stabilizes hypoxia-inducible factor 1alpha and stimulates the synthesis of vascular endothelial growth factor. J Virol. 81:10249–10257. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Ripoli M, D’Aprile A, Quarato G, Sarasin-Filipowicz M, Gouttenoire J, Scrima R, Cela O, Boffoli D, Heim MH, Moradpour D, et al: Hepatitis C virus-linked mitochondrial dysfunction promotes hypoxia-inducible factor 1 alpha-mediated glycolytic adaptation. J Virol. 84:647–660. 2010. View Article : Google Scholar | |
|
Liu XH, Zhou X, Zhu CL, Song H and Liu F: Effects of HCV core protein on the expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor. Zhonghua Gan Zang Bing Za Zhi. 19:751–754. 2011.(In Chinese). | |
|
Abe M, Koga H, Yoshida T, Masuda H, Iwamoto H, Sakata M, Hanada S, Nakamura T, Taniguchi E, Kawaguchi T, et al: Hepatitis C virus core protein upregulates the expression of vascular endothelial growth factor via the nuclear factor-κB/hypoxia-inducible factor-1α axis under hypoxic conditions. Hepatol Res. 42:591–600. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Mesri EA, Cesarman E and Boshoff C: Kaposi’s sarcoma and its associated herpesvirus. Nat Rev Cancer. 10:707–719. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Cesarman E, Chang Y, Moore PS, Said JW and Knowles DM: Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med. 332:1186–1191. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Cai Q, Murakami M, Si H and Robertson ES: A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi’s sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia. J Virol. 81:10413–10423. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Cotter MA II and Robertson ES: The latency-associated nuclear antigen tethers the Kaposi’s sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology. 264:254–264. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Cai Q, Lan K, Verma SC, Si H, Lin D and Robertson ES: Kaposi’s sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions. J Virol. 80:7965–7975. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Cai QL, Knight JS, Verma SC, Zald P and Robertson ES: EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors. PLoS Pathog. 2:e1162006. View Article : Google Scholar : PubMed/NCBI | |
|
Rivas C, Thlick AE, Parravicini C, Moore PS and Chang Y: Kaposi’s sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J Virol. 75:429–438. 2001. View Article : Google Scholar | |
|
Shin YC, Joo CH, Gack MU, Lee HR and Jung JU: Kaposi’s sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expression. Cancer Res. 68:1751–1759. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Sodhi A, Montaner S, Patel V, Zohar M, Bais C, Mesri EA and Gutkind JS: The Kaposi’s sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Cancer Res. 60:4873–4880. 2000.PubMed/NCBI | |
|
Jham BC, Ma T, Hu J, Chaisuparat R, Friedman ER, Pandolfi PP, Schneider A, Sodhi A and Montaner S: Amplification of the angiogenic signal through the activation of the TSC/mTOR/HIF axis by the KSHV vGPCR in Kaposi’s sarcoma. PLoS One. 6:e191032011. View Article : Google Scholar | |
|
Davis DA, Rinderknecht AS, Zoeteweij JP, Aoki Y, Read-Connole EL, Tosato G, Blauvelt A and Yarchoan R: Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus. Blood. 97:3244–3250. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Samaras V, Rafailidis PI, Mourtzoukou EG, Peppas G and Falagas ME: Chronic bacterial and parasitic infections and cancer: A review. J Infect Dev Ctries. 4:267–281. 2010.PubMed/NCBI | |
|
Nizet V and Johnson RS: Interdependence of hypoxic and innate immune responses. Nat Rev Immunol. 9:609–617. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Dorer MS, Talarico S and Salama NR: Helicobacter pylori’s unconventional role in health and disease. PLoS Pathog. 5:e10005442009. View Article : Google Scholar | |
|
Nardone G, Rocco A and Malfertheiner P: Review article: Helicobacter pylori and molecular events in precancerous gastric lesions. Aliment Pharmacol Ther. 20:261–270. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Griffiths EA, Pritchard SA, Valentine HR, Whitchelo N, Bishop PW, Ebert MP, Price PM, Welch IM and West CM: Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas. Br J Cancer. 96:95–103. 2007. View Article : Google Scholar | |
|
Griffiths EA, Pritchard SA, McGrath SM, Valentine HR, Price PM, Welch IM and West CM: Increasing expression of hypoxia-inducible proteins in the Barrett’s metaplasia-dysplasia-adenocarcinoma sequence. Br J Cancer. 96:1377–1383. 2007.PubMed/NCBI | |
|
Park JH, Kim TY, Jong HS, Kim TY, Chun YS, Park JW, Lee CT, Jung HC, Kim NK and Bang YJ: Gastric epithelial reactive oxygen species prevent normoxic degradation of hypoxia-inducible factor-1alpha in gastric cancer cells. Clin Cancer Res. 9:433–440. 2003.PubMed/NCBI | |
|
Bhattacharyya A, Chattopadhyay R, Hall EH, Mebrahtu ST, Ernst PB and Crowe SE: Mechanism of hypoxia-inducible factor 1 alpha-mediated Mcl1 regulation in Helicobacter pylori-infected human gastric epithelium. Am J Physiol Gastrointest Liver Physiol. 299:G1177–G1186. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Ohshima H and Bartsch H: Chronic infections and inflammatory processes as cancer risk factors: Possible role of nitric oxide in carcinogenesis. Mutat Res. 305:253–264. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Mannick EE, Bravo LE, Zarama G, Realpe JL, Zhang XJ, Ruiz B, Fontham ET, Mera R, Miller MJ and Correa P: Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: Effect of antibiotics and antioxidants. Cancer Res. 56:3238–3243. 1996.PubMed/NCBI | |
|
Metzen E, Zhou J, Jelkmann W, Fandrey J and Brüne B: Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases. Mol Biol Cell. 14:3470–3481. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Yuan C, Zhu C, Wu Y, Pan X and Hua X: Bacteriological and molecular identification of Bartonella species in cats from different regions of China. PLoS Negl Trop Dis. 5:e13012011. View Article : Google Scholar : PubMed/NCBI | |
|
Kempf VA, Lebiedziejewski M, Alitalo K, Wälzlein JH, Ehehalt U, Fiebig J, Huber S, Schütt B, Sander CA, Müller S, et al: Activation of hypoxia-inducible factor-1 in bacillary angiomatosis: Evidence for a role of hypoxia-inducible factor-1 in bacterial infections. Circulation. 111:1054–1062. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Relman DA, Falkow S, LeBoit PE, Perkocha LA, Min KW, Welch DF and Slater LN: The organism causing bacillary angiomatosis, peliosis hepatis, and fever and bacteremia in immunocompromised patients. N Engl J Med. 324:15141991. View Article : Google Scholar : PubMed/NCBI | |
|
Kaiser PO, Riess T, Wagner CL, Linke D, Lupas AN, Schwarz H, Raddatz G, Schäfer A and Kempf VA: The head of Bartonella adhesin A is crucial for host cell interaction of Bartonella henselae. Cell Microbiol. 10:2223–2234. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Porta C, Riboldi E and Sica A: Mechanisms linking pathogens-associated inflammation and cancer. Cancer Lett. 305:250–262. 2011. View Article : Google Scholar | |
|
Mostafa MH, Sheweita SA and O’Connor PJ: Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev. 12:97–111. 1999.PubMed/NCBI | |
|
Vennervald BJ and Polman K: Helminths and malignancy. Parasite Immunol. 31:686–696. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Araújo AP, Frezza TF, Allegretti SM and Giorgio S: Hypoxia, hypoxia-inducible factor-1α and vascular endothelial growth factor in a murine model of Schistosoma mansoni infection. Exp Mol Pathol. 89:327–333. 2010. View Article : Google Scholar | |
|
Wilson MS, Mentink-Kane MM, Pesce JT, Ramalingam TR, Thompson R and Wynn TA: Immunopathology of schistosomiasis. Immunol Cell Biol. 85:148–154. 2007. View Article : Google Scholar | |
|
Arrais-Silva WW, Paffaro VA Jr, Yamada AT and Giorgio S: Expression of hypoxia-inducible factor-1alpha in the cutaneous lesions of BALB/c mice infected with Leishmania amazonensis. Exp Mol Pathol. 78:49–54. 2005. View Article : Google Scholar | |
|
Degrossoli A, Bosetto MC, Lima CB and Giorgio S: Expression of hypoxia-inducible factor 1alpha in mononuclear phagocytes infected with Leishmania amazonensis. Immunol Lett. 114:119–125. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Singh AK, Mukhopadhyay C, Biswas S, Singh VK and Mukhopadhyay CK: Intracellular pathogen Leishmania donovani activates hypoxia inducible factor-1 by dual mechanism for survival advantage within macrophage. PLoS One. 7:e384892012. View Article : Google Scholar : PubMed/NCBI | |
|
Morsy TA: Cutaneous leishmaniasis predisposing to human skin cancer: Forty years local and regional studies. J Egypt Soc Parasitol. 43:629–648. 2013. View Article : Google Scholar | |
|
Suzuki H, Iwasaki E and Hibi T: Helicobacter pylori and gastric cancer. Gastric Cancer. 12:79–87. 2009. View Article : Google Scholar : PubMed/NCBI |
